Role of gut microbiota in liver diseases (Q37488165)

20 August 2017

Role of gut microbiota in liver diseases (English)

1 reference

20 August 2017

Yasuhiro Miyake

1

1 reference

PMCID

3894231

20 August 2017

Kazuhide Yamamoto

series ordinal

2

1 reference

20 August 2017

13 September 2012

1 reference

20 August 2017

1 reference

20 August 2017

43

1 reference

20 August 2017

139-146

1 reference

20 August 2017

2

1 reference

PRMT5 modulates the metabolic response to fasting signals

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Gut microbiome, obesity, and metabolic dysfunction

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Intrahepatic natural killer T cell populations are increased in human hepatic steatosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

An obesity-associated gut microbiome with increased capacity for energy harvest

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Glycolipid antigen induces long-term natural killer T cell anergy in mice

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

The gut microbiota as an environmental factor that regulates fat storage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

The composition of intrahepatic lymphocytes: shaped by selective recruitment?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

A simple method for the isolation and purification of total lipides from animal tissues

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Probiotics, prebiotics, and synbiotics--approaching a definition

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

The role of the gut microbiota in nonalcoholic fatty liver disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Recognition of bacterial glycosphingolipids by natural killer T cells

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

NKT cells: what's in a name?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

The prevalence and etiology of elevated aminotransferase levels in the United States

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3894231

Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver.

2 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Mechanisms of disease progression in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Inflammasomes in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Primary sclerosing cholangitis: epidemiology, natural history, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Genome-wide association identifies multiple ulcerative colitis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Dectin-1 is a major beta-glucan receptor on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

beta-Glucans and dectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Intestinal microbiota regulate xenobiotic metabolism in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Hepatic IL-17 responses in human and murine primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing Cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01088.X

10.1111/J.1872-034X.2012.01088.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

PMCID

3894231